News
MTX-001 is also being studied in an ongoing multicenter, Phase 2 double-blind, placebo-controlled trial focused on venous leg ulcers (VLUs). The company is actively expanding collaborations with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback